Connectivity mapping of angiotensin-PPAR interactions involved in the amelioration of non-alcoholic steatohepatitis by Telmisartan
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-019-40322-1.pdf
Reference47 articles.
1. Musso, G., Gambino, R. & Cassader, M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obesity reviews: an official journal of the International Association for the Study of Obesity 11, 430–445, https://doi.org/10.1111/j.1467-789X.2009.00657.x (2010).
2. Fan, J. G. & Farrell, G. C. Epidemiology of non-alcoholic fatty liver disease in China. Journal of hepatology 50, 204–210, https://doi.org/10.1016/j.jhep.2008.10.010 (2009).
3. Caligiuri, A., Gentilini, A. & Marra, F. Molecular Pathogenesis of NASH. International journal of molecular sciences 17, https://doi.org/10.3390/ijms17091575 (2016).
4. Lefebvre, P. et al. Interspecies NASH disease activity whole-genome profiling identifies a fibrogenic role of PPARalpha-regulated dermatopontin. JCI insight 2, https://doi.org/10.1172/jci.insight.92264 (2017).
5. Angulo, P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance? Hepatology 51, 373–375, https://doi.org/10.1002/hep.23521 (2010).
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hyaluronic acid stimulation of stem cells for cardiac repair: a cell-free strategy for myocardial infarct;Journal of Nanobiotechnology;2024-04-04
2. Genetic Variation in Angiotensin II Type 1 Receptor Is Linked to Lipid Levels and Hepatic Steatosis in Alcohol-Associated Liver Disease, but Not to Cirrhosis or Hepatocellular Carcinoma;Gastroenterology Insights;2024-01-03
3. Hyaluronic acid stimulation of stem cells for cardiac repair: a cell-free strategy for myocardial infarct;2023-10-31
4. Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure;Current Heart Failure Reports;2023-07-04
5. Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease;Journal of Controlled Release;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3